BeOne Medicines Ltd ADR (NASDAQ: ONC) started the day on Wednesday, with a price increase of 1.63% at $340.64, before settling in for the price of $335.17 at the close. Taking a more long-term approach, ONC posted a 52-week range of $170.99-$385.22.
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 17.28%. Meanwhile, its Annual Earning per share during the time was 17.28%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 146.03%. This publicly-traded company’s shares outstanding now amounts to $101.77 million, simultaneously with a float of $101.28 million. The organization now has a market capitalization sitting at $34.66 billion. At the time of writing, stock’s 50-day Moving Average stood at $332.64, while the 200-day Moving Average is $283.18.
BeOne Medicines Ltd ADR (ONC) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Biotechnology Industry. BeOne Medicines Ltd ADR’s current insider ownership accounts for 0.46%, in contrast to 32.24% institutional ownership. Preceding that transaction, on Nov 17 ’25, Company’s President and COO sold 3,991 for 380.43, making the whole transaction’s value amount to 1,518,303. This particular insider is now the holder of 0 in total.
BeOne Medicines Ltd ADR (NASDAQ: ONC) Trading Performance Indicators
Let’s observe the current performance indicators for BeOne Medicines Ltd ADR (ONC). It’s Quick Ratio in the last reported quarter now stands at 2.17. Alongside those numbers, its PE Ratio stands at $655.33, and its Beta score is 0.45. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.97. Similarly, its price to free cash flow for trailing twelve months is now 63.51.
In the same vein, ONC’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.52, a figure that is expected to reach 1.50 in the next quarter, and analysts are predicting that it will be 6.48 at the market close of one year from today.
Technical Analysis of BeOne Medicines Ltd ADR (ONC)
If we take a close look at the recent performances of BeOne Medicines Ltd ADR (NASDAQ: ONC), its last 5-days Average volume was 0.35 million that shows plunge from its year to date volume of 0.39 million. During the previous 9 days, stock’s Stochastic %D was recorded 21.91% While, its Average True Range was 48.30.
Raw Stochastic average of BeOne Medicines Ltd ADR (ONC) in the period of the previous 100 days is set at 67.27%, which indicates a major rise in contrast to 38.38% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 14.61 that was higher than 8.99 volatility it exhibited in the past 100-days period.
